Cargando…
A patient with COVID-19 and bleeding complications due to neurofibromatosis type 1 during VV-ECMO: A case report
RATIONALE: The many deaths from coronavirus disease (COVID-19) since 2019 have caused global concern. Effective treatment has not yet been established; supportive care is the main treatment. It has been suggested that veno-venous extracorporeal membrane oxygenation (VV-ECMO) may be effective in seve...
Autores principales: | Shimoyama, Keiichiro, Azuma, Kazunari, Oda, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702218/ https://www.ncbi.nlm.nih.gov/pubmed/34941051 http://dx.doi.org/10.1097/MD.0000000000028094 |
Ejemplares similares
-
VV-ECMO combined with prone position ventilation in the treatment of Pneumocystis jirovecii pneumonia: A case report
por: Jia, Lijing, et al.
Publicado: (2022) -
Dynamic coagulofibrinolytic responses under long-term VV-ECMO management without anticoagulation in a COVID-19-ARDS patient: A case report
por: Matsumoto, Hironori, et al.
Publicado: (2023) -
Bilateral dilated nonreactive pupils secondary to rocuronium infusion in an ARDS patient treated with ECMO therapy: A case report
por: He, Huaiwu, et al.
Publicado: (2020) -
ECMO Used in a Refractory Ventricular Tachycardia and Ventricular Fibrillation Patient: A National Case–Control Study
por: Chen, Chih-Yu, et al.
Publicado: (2016) -
Bleeding Complications in COVID-19 Critically Ill ARDS Patients Receiving VV-ECMO Therapy
por: Flinspach, Armin Niklas, et al.
Publicado: (2023)